Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species (Q35641652)

9 August 2017

Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species (English)

1 reference

9 August 2017

1 reference

1 reference

Marianne McCollum

1

1 reference

9 August 2017

David C Rhew

series ordinal

2

1 reference

9 August 2017

Stephen Parodi

series ordinal

3

1 reference

9 August 2017

language of work or name

1 reference

1 December 2003

1 reference

9 August 2017

Clinical Therapeutics

1 reference

9 August 2017

25

1 reference

9 August 2017

12

1 reference

9 August 2017

3173-3189

1 reference

Benchmark analysis of strategies hospitals use to control antimicrobial expenditures

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Pitfalls associated with commonly used methods for pharmacoeconomic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Modeling for health care and other policy decisions: uses, roles, and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Pharmacoeconomic analyses: making them transparent, making them credible

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

The economic impact of Staphylococcus aureus infection in New York City hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Methicillin-resistant Staphylococcus aureus: long-term care concerns

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Early Switch and Early Discharge Opportunities in Intravenous Vancomycin Treatment of Suspected Methicillin-Resistant Staphylococcal Species Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Peripherally inserted central catheters: outcome as a function of the operator

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Complication rates among cancer patients with peripherally inserted central catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Intravenous-to-oral antibiotic switch therapy. A cost-effective approach

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Consequences of intravascular catheter sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

The epidemiology of peripheral vein infusion thrombophlebitis: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Controversial issues in the care and maintenance of vascular access devices in the long-term/subacute care client

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Nurse-Staffing Levels and the Quality of Care in Hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Changing concepts in long-term central venous access: catheter selection and cost savings

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

Cost perspectives for outpatient intravenous antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990101-9

7 January 2021

10.1016/S0149-2918(03)90101-9

Identifiers

DOI

1 reference

9 August 2017

1 reference